Raymond James & Associates’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-2,906
| Closed | -$74K | – | 3443 |
|
|
2017
Q4 | $74K | Sell |
2,906
-3,606
| -55% | -$91.8K | ﹤0.01% | 3196 |
|
|
2017
Q3 | $183K | Buy |
6,512
+1,501
| +30% | +$42.2K | ﹤0.01% | 3050 |
|
|
2017
Q2 | $150K | Sell |
5,011
-359
| -7% | -$10.7K | ﹤0.01% | 3022 |
|
|
2017
Q1 | $160K | Sell |
5,370
-211
| -4% | -$6.29K | ﹤0.01% | 2956 |
|
|
2016
Q4 | $193K | Sell |
5,581
-353
| -6% | -$12.2K | ﹤0.01% | 2868 |
|
|
2016
Q3 | $392K | Sell |
5,934
-31
| -0.5% | -$2.05K | ﹤0.01% | 2432 |
|
|
2016
Q2 | $338K | Buy |
5,965
+298
| +5% | +$16.9K | ﹤0.01% | 2336 |
|
|
2016
Q1 | $330K | Buy |
5,667
+136
| +2% | +$7.92K | ﹤0.01% | 2264 |
|
|
2015
Q4 | $325K | Buy |
5,531
+160
| +3% | +$9.4K | ﹤0.01% | 2163 |
|
|
2015
Q3 | $307K | Buy |
5,371
+1
| +0% | +$57 | ﹤0.01% | 2120 |
|
|
2015
Q2 | $485K | Sell |
5,370
-44
| -0.8% | -$3.97K | ﹤0.01% | 2100 |
|
|
2015
Q1 | $521K | Sell |
5,414
-43
| -0.8% | -$4.14K | ﹤0.01% | 2018 |
|
|
2014
Q4 | $478K | Sell |
5,457
-353
| -6% | -$30.9K | ﹤0.01% | 1956 |
|
|
2014
Q3 | $531K | Sell |
5,810
-1,246
| -18% | -$114K | ﹤0.01% | 1824 |
|
|
2014
Q2 | $812K | Buy |
7,056
+1,688
| +31% | +$194K | 0.01% | 1612 |
|
|
2014
Q1 | $650K | Sell |
5,368
-3,053
| -36% | -$370K | ﹤0.01% | 1659 |
|
|
2013
Q4 | $1.06M | Buy |
8,421
+302
| +4% | +$38K | 0.01% | 1295 |
|
|
2013
Q3 | $883K | Buy |
8,119
+2,618
| +48% | +$285K | 0.01% | 1323 |
|
|
2013
Q2 | $463K | Buy |
+5,501
| New | +$463K | ﹤0.01% | 1541 |
|